Navigation Links
New Orthopedic Oncology Fellowship Program at Mount Clemens Brings Highly Trained Surgeons to State
Date:11/12/2008

Fellowship First In State To Train Surgeons For Rare But Often Mistreated

Cancer New Program Is Example Of Growth And Momentum At Mount Clemens Regional

Medical Center

MOUNT CLEMENS, Mich., Nov. 12 /PRNewswire/ -- The first fellowship program in the state for musculoskeletal tumors kicked off Oct. 1 at Mount Clemens Regional Medical Center under the stewardship of Ronald Irwin, M.D., an internationally known specialist in the diagnosis and treatment of bone cancers. Dr. Kenyatta Norman became the first orthopedic oncology fellow in Michigan last month. A second fellow is expected to be added to the program next year.

"The orthopedic oncology fellowship program is just one example of the investment and growth we're experiencing at Mount Clemens Regional Medical Center," said MCRMC President and CEO Mark O'Halla. "There are exciting things happening at Mount Clemens Regional and McLaren Health Care. Being able to attract top talent to create new programs that will benefit our patients and region are indicative of that."

Musculoskeletal tumors can occur in the muscles, nerves or the bones of the limbs. They can be primary tumors, or metastatic sites from other cancers. Because they are rare tumors, there are few experienced surgeons in orthopedic oncology that can accurately diagnose them, which sometimes leads to mistreatment of the tumors.

Irwin is one of the top-rated orthopedic oncologists in the country and one of only approximately 75 members worldwide of the Musculoskeletal Tumor Society. In addition to serving as Director of the Orthopedic Oncology at Mount Clemens Regional Medical Center, and Associate Director of McLaren Health Care's six Great Lakes Cancer Institute locations, Irwin teaches post- graduate physicians and orthopedic residents and medical students throughout the state. He has also co-authored a textbook chapter and published in some of the leading orthopedic medical journals. Irwin received his undergraduate and medical degrees at the University of Michigan, conducted his residency at the William Beaumont Hospital and fellowship at the Mayo Clinic, as well as limb salvage sabbatical at Harvard University.

Before joining Mount Clemens Regional, Irwin had served as the Executive Vice President and Chief Medical Officer of Beaumont Hospitals, as well as Corporate Director of Oncology Services and Director of the Musculoskeletal Tumor Services.

Norman completed her undergraduate and medical degree at Indiana University, and her orthopedic residency at Howard University. She is one of only 12 fellows training in orthopedic oncology in the nation.

"Including myself, there are only 12 surgeons training fellows in this specialty in the nation," Irwin said. "We see this as a wonderful opportunity to bring highly skilled surgeons to Southeast Michigan, and offer their talents to provide the best treatment available to our patients."


'/>"/>
SOURCE McLaren Health Care
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
2. Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 2007
3. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes
4. QED International Announces Changes to the HealthShares(TM) Orthopedic Repair Index
5. Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling Over $3.5 Million of Annual Net Revenue
6. Orthopedic Surgeon Contributes Knowledge on Research and Treatment in Weekly Blogs on MyOsteoarthritisCentral.com
7. Hanger Orthopedic Group, Inc. Announces 2007 Year-End Earnings Release Conference Call
8. Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
9. Ascension Orthopedics Launches the TITAN(TM) Humeral Resurfacing Device World Wide
10. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
11. Hanger Orthopedic Group, Inc. Announces an 11% Sales Increase and a 35% Increase in EPS to $0.23 for the Quarter Ended December 31, 2007, Compared to $0.17 in the Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: